XML 32 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1

Restructuring Activities (Notes)

3 Months Ended

Mar. 31, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Related Activities Disclosure [Text Block]

Restructuring Activities

Due to economic conditions, including low energy prices and global competition, the Company implemented a number of cost reduction or avoidance actions, including headcount reductions and facility closures and relocations relating to the consolidation of certain of our facilities in China, Buffalo BioMedical respiratory consolidation, and relocation of the Corporate headquarters.

The following table is a summary of the severance and other restructuring charges for the first quarter ended March 31, 2017 and March 31, 2016:

	March 31, 2017				March 31, 2016
Severance:
Cost of sales	$	648			$	2,361
Selling, general, and administrative expenses	692				1,331
Total severance charges	$	1,340			$	3,692
Other restructuring:
Cost of sales	$	1,826			$	—
Selling, general, and administrative expenses	1,460				281
Total other restructuring charges	$	3,286			$	281
Total restructuring charges	$	4,626			$	3,973

The Company is closely monitoring its end markets and order rates and will continue to take appropriate and timely actions as necessary. The Company currently expects additional restructuring expenses in the remaining nine months of 2017 to be approximately $8,300 ($3,000 - E&C, $1,300 - D&S, $1,300 - BioMedical, and $2,700 - Corporate), but further actions may be required based on future business conditions.

The following tables summarize the Company’s restructuring activities for the three months ended March 31, 2017 and 2016:

	Three Months Ended March 31, 2017
	Energy & Chemicals				Distribution & Storage				BioMedical				Corporate				Total
Balance as of December 31, 2016	$	127			$	2,864			$	1,308			$	3,025			$	7,324
Restructuring charges	426				137				2,604				1,459				4,626
Cash payments and other	(553		)		(736		)		(2,473		)		(1,553		)		(5,315		)
Balance as of March 31, 2017	$	—			$	2,265			$	1,439			$	2,931			$	6,635

	Three Months Ended March 31, 2016
	Energy & Chemicals				Distribution & Storage				BioMedical				Corporate				Total
Balance as of December 31, 2015	$	1,106			$	3,446			$	430			$	850			$	5,832
Restructuring charges	292				2,193				484				1,004				3,973
Cash payments and other	(854		)		(385		)		(440		)		(779		)		(2,458		)
Balance as of March 31, 2016	$	544			$	5,254			$	474			$	1,075			$	7,347

X

- References

No definition available.

+ Details

Name:	us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4)
-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

+ Details

Name:	us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration